1. Home
  2. HPH vs HBIO Comparison

HPH vs HBIO Comparison

Compare HPH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPH
  • HBIO
  • Stock Information
  • Founded
  • HPH 2010
  • HBIO 1901
  • Country
  • HPH China
  • HBIO United States
  • Employees
  • HPH N/A
  • HBIO N/A
  • Industry
  • HPH
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • HPH
  • HBIO Industrials
  • Exchange
  • HPH NYSE
  • HBIO Nasdaq
  • Market Cap
  • HPH 65.9M
  • HBIO 61.2M
  • IPO Year
  • HPH 2019
  • HBIO 2000
  • Fundamental
  • Price
  • HPH $0.20
  • HBIO $0.99
  • Analyst Decision
  • HPH
  • HBIO
  • Analyst Count
  • HPH 0
  • HBIO 0
  • Target Price
  • HPH N/A
  • HBIO N/A
  • AVG Volume (30 Days)
  • HPH 161.6K
  • HBIO 284.5K
  • Earning Date
  • HPH 01-01-0001
  • HBIO 03-06-2025
  • Dividend Yield
  • HPH N/A
  • HBIO N/A
  • EPS Growth
  • HPH N/A
  • HBIO N/A
  • EPS
  • HPH N/A
  • HBIO N/A
  • Revenue
  • HPH $286,996,105.00
  • HBIO $97,732,000.00
  • Revenue This Year
  • HPH N/A
  • HBIO N/A
  • Revenue Next Year
  • HPH N/A
  • HBIO $4.32
  • P/E Ratio
  • HPH N/A
  • HBIO N/A
  • Revenue Growth
  • HPH 1722.42
  • HBIO N/A
  • 52 Week Low
  • HPH $0.20
  • HBIO $0.94
  • 52 Week High
  • HPH $10.06
  • HBIO $4.70
  • Technical
  • Relative Strength Index (RSI)
  • HPH 36.35
  • HBIO 16.00
  • Support Level
  • HPH $0.20
  • HBIO $1.26
  • Resistance Level
  • HPH $0.23
  • HBIO $1.43
  • Average True Range (ATR)
  • HPH 0.02
  • HBIO 0.10
  • MACD
  • HPH -0.00
  • HBIO -0.03
  • Stochastic Oscillator
  • HPH 2.57
  • HBIO 6.05

About HPH HIGHEST PERFORMANCE HLDGS INC

Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. The Group operate theree segments: (1) the insurance agency segment, which mainly consists of providing agency services for a wide range of life and non-life insurance products to individual clients, (2) the claims adjusting segment, which consists of providing pre-underwriting survey services, claim adjusting services, disposal of residual value services, loading and unloading supervision services, and consulting services, and (3) the wealth management segment, which mainly consists of providing distribution and managing wealth management services. Maximum revenue is from The Insurance Agency Segment.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: